Alexa Fluor® 568 Anti-CD19 抗体 [SP291] - C-terminal
Alexa Fluor® 568 Anti-CD19 antibody [SP291] - C-terminal
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CD19 antibody - conjugated to Alexa Fluor® 568.
別名を表示する
CD19, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12
関連する標識済み抗体及び組成の異なる製品 (10)
-
Anti-CD19 antibody [SP291] - C-terminal
-
578 PE
PE Anti-CD19 antibody [SP291] (C-terminal)
-
660 APC
APC Anti-CD19 antibody [SP291] (C-terminal)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD19 antibody [SP291] - C-terminal
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD19 antibody [SP291] - C-terminal
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD19 antibody [SP291] - C-terminal
-
HRP Anti-CD19 antibody [SP291] (C-terminal)
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD19 antibody [SP291] - C-terminal
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CD19 antibody [SP291] - C-terminal
-
Anti-CD19 antibody [SP291] - BSA and Azide free
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD19 acts as an essential player in B cell signaling. CD19 integrates signals from the BCR with other coreceptors acting as a signaling hub. It participates in forming a signaling complex that includes proteins like CD21 and CD81 which further amplifies BCR-mediated signaling. This complex plays a critical role in B cell activation differentiation and survival ensuring that immune responses are efficiently mounted against pathogens.
Pathways
The CD19 protein fits into key immune response pathways such as the BCR signaling pathway and the PI3K-Akt signaling pathway. CD19 collaborates with other proteins like CD21 CD81 and PI3K within these pathways. Its interaction in the PI3K-Akt pathway for instance supports critical processes including B cell activation and homeostasis contributing to the adaptive immune response.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
Abcam product promise
関連製品
Alternative Version
Primary Antibodies
AB237772
Anti-CD19 antibody [SP291] - BSA and Azide free
primary-antibodies
cd19-antibody-sp291-bsa-and-azide-free-ab237772
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com